Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Article

J App Pharm Sci. 2014; 4(11): 054-061

Formulation of Desloratadine Oral Disintegrating Tablets

Mohamed A. Etman, Mona Gamal, Aly H. Nada, Mohamed A. Shams-Eldeen.

Desloratadine (DS) is a tricyclic antihistaminic, characterized bitter taste and slight water solubility. The aim of this study is to prepare DS as orally disintegrating tablets (ODT) to mask the bitter taste and improve compliance.
Twelve different placebo ODT (F1-F12) were prepared using mannitol as diluent, in addition to functional. The formulations were evaluated for relevant in vitro characteristics. DS powder was treated by different techniques and polymers (hydroxypropyl methyl cellulose (HPMC), Eudragit RL 30, and Eudragit EPO) for taste masking of DS. The placebo and DS- ODT tablets were assessed for taste masking efficiency by a panel of 10 volunteers.
All placebo formulations were non sticky except four formulations (F8- F11), and compressible with the exception of F2. F12 showed the least disintegration time (20 sec) without sticking tendency. The compressible non sticky formulations were used for preparation of DS tablets and subjected to further in vitro evaluation. Fairly good weight uniformity values were observed in all the tested ODT formulations. F12 exhibiting the shortest wetting time (14.7 seconds) and the least disintegration time (20 seconds). 100% DS release was attained after 2.5 min DS-ODT, compared to 82% from conventional marketed tablets (Aerius®) at same time interval.

Key words: Desloratadine, Oral Disintegrating Tablets, In vitro tests, Taste masking,

Share this Article

Journal of Interdisciplinary Histopathology


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.